Shai Mulinari

1 – 10 of 101

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/25ef8252-f7b7-4359-8fba-030a7414ec7f?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
…
10
11
next »

2025
Mark Patterns of company misconduct, recidivism, and complaint resolution delays : A temporal analysis of UK pharmaceutical industry self-regulation within the European context
Mulinari, Shai ^LU ; Pashley, Dylan ^LU and Ozieranski, Piotr (2025) In Regulation and Governance 19(1). p.200-217
- Contribution to journal › Article
Mark Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed
Nilsonne, Gustav ; Wieschowski, Susanne ; DeVito, Nicholas J ; Salholz-Hillel, Maia ; Ahnström, Love ; Bruckner, Till ; Klas, Katarzyna ; Suljic, Tarik ; Yerunkar, Samruddhi and Olsson, Natasha , et al. (2025) In Journal of Clinical Epidemiology 181.
- Contribution to journal › Article
Mark Unknowns of drug company payment disclosure : why the UK needs payment transparency legislation
Ozieranski, Piotr ; Rickard, Emily and Mulinari, Shai ^LU (2025) In BMJ Evidence-Based Medicine
- Contribution to journal › Article
Mark Pharmaceutical industry payments to patient organizations in Poland : Analysis of the patterns, evolution, and structure of connections
Makowska, Marta ; Mulinari, Shai ^LU and Ozieranski, Piotr (2025) In International journal of social determinants of health and health services 55(2). p.199-212
- Contribution to journal › Article
Mark Self-regulation of UK's pharmaceutical industry
Ozieranski, Piotr ; Mulinari, Shai ^LU ; Colombo, Cinzia and Mintzes, Barbara (2025) In BMJ (Clinical research ed.) 389. p.1065-1065
- Contribution to journal › Debate/Note/Editorial
Mark Det är dags att Läkartidningen slutar med läkemedelsannonser
Mulinari, Shai ^LU ; Svensson, Staffan ; Ringsten, Martin ^LU ; Bruschettini, Matteo ^LU ; Jørgensen, Karsten Juhl ; Boesen, Kim and Marx, André (2025) In Läkartidningen
- Contribution to journal › Debate/Note/Editorial
Mark Evaluating time to withdrawal of anti-cancer drug indications that received FDA's accelerated approval
Hakariya, Hayase ; Ozaki, Akihiko ; Mulinari, Shai ^LU ; Moriarty, Frank and Tanimoto, Tetsuya (2025) In QJM - Monthly Journal of the Association of Physicians 118(1). p.3-4
- Contribution to journal › Article
Mark Pharmaceutical company promotional payments to English general practices: : longitudinal study
Mulinari, Shai ^LU ; Malik, Minahil ^LU ; Larkin, James ; Elsharkawy, Mostafa ; Fahey, Tom ; Moriarty, Frank and Ozieranski, Piotr (2025) In BJGP open
- Contribution to journal › Article
Mark Lost along the way? : Searching for the inclusion-and-difference paradigm in pharmaceutical research and regulation in Sweden
Bredström, Anna and Mulinari, Shai ^LU (2025) In Behemoth 18. p.28-28
- Contribution to journal › Article
2024
Mark Delays in dealing with complaints against drug companies are growing, BMJ finds
Boytchev, Hristio ; Mulinari, Shai ^LU and Ozieranski, Piotr (2024) In BMJ (Clinical research ed.) 384. p.365-365
- Contribution to specialist publication or newspaper › Specialist publication article

« previous
1
2
3
4
…
10
11
next »